Sonoma Pharmaceuticals Inc (SNOA)

Jan 05, 2025

Sonoma Pharmaceuticals announces executive equity grants By Investing.com - Investing.com Australia

Jan 05, 2025

Jan 05, 2025

Sonoma Pharmaceuticals announces executive equity grants - Investing.com India

Jan 05, 2025

Dec 31, 2024

Despite Fast-paced Momentum, Sonoma Pharmaceuticals (SNOA) Is Still a Bargain Stock - MSN

Dec 31, 2024

Dec 28, 2024

Sonoma Pharmaceuticals, Inc. Announces Two Singapore Approvals for Microcyn for the Treatment of Atopic Dermatitis and Hypertrophic / Keloid Scars - Marketscreener.com

Dec 28, 2024

Dec 23, 2024

Keloid Treatment Market Top PlayersNovartis AG, Sensus - openPR

Dec 23, 2024

Dec 20, 2024

Sonoma Pharmaceuticals (NASDAQ:SNOA) Stock Crosses Above Two Hundred Day Moving Average – Here’s What Happened - Defense World

Dec 20, 2024

Dec 18, 2024

SNOA stock touches 52-week low at $2.44 amid market challenges - Investing.com

Dec 18, 2024

Dec 18, 2024

SNOA stock touches 52-week low at $2.44 amid market challenges By Investing.com - Investing.com South Africa

Dec 18, 2024

Dec 09, 2024

Sonoma Pharmaceuticals (SNOA) Stock Surges Amid Market Fluctuati - GuruFocus.com

Dec 09, 2024

Dec 07, 2024

SNOA Stock Hits 52-Week Low at $2.47 Amid Market Challenges - Investing.com Canada

Dec 07, 2024

Dec 06, 2024

SNOA Stock Hits 52-Week Low at $2.47 Amid Market Challenges By Investing.com - Investing.com South Africa

Dec 06, 2024

Dec 05, 2024

Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices - AccessWire

Dec 05, 2024

Dec 03, 2024

Sonoma Pharmaceuticals (SNOA) Stock Declines Amid Market Activit - GuruFocus.com

Dec 03, 2024

Nov 30, 2024

Sonoma Pharmaceuticals (STU:O8Z) PE Ratio : At Loss (As of Nov. 30, 2024) - GuruFocus.com

Nov 30, 2024

Nov 30, 2024

SNOA (Sonoma Pharmaceuticals) Debt-to-Equity : 0.05 (As of Sep. 2024) - GuruFocus.com

Nov 30, 2024

Nov 26, 2024

Sonoma Pharmaceuticals (STU:O8Z) Growth Rank : 2 (As of Nov. 26, 2024) - GuruFocus.com

Nov 26, 2024

Nov 23, 2024

Eye Care Product Lines - Trend Hunter

Nov 23, 2024

Nov 22, 2024

Alkermes (ALKS) Stock Surges Over 5% Amid Strong Financial Perfo - GuruFocus.com

Nov 22, 2024

Nov 22, 2024

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in the United States - BioSpace

Nov 22, 2024

Nov 22, 2024

Sonoma Pharmaceuticals, Inc. Receives New FDA 510(K) Clearance for Microcyn(R)-Based Wound Care Hydrogel - Marketscreener.com

Nov 22, 2024

Nov 22, 2024

Scar Treatment Market Detailed In New Research Report 2024 | - openPR

Nov 22, 2024

Nov 22, 2024

Sonoma Pharmaceuticals ends agreement with EMC Pharma - Investing.com

Nov 22, 2024

Nov 21, 2024

Merck (MRK) Stock Surges Amid Industry Layoff Trends - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Sonoma Pharmaceuticals ends agreement with EMC Pharma By Investing.com - Investing.com Australia

Nov 21, 2024

Nov 21, 2024

Sonoma Pharmaceuticals Announces Relaunch of Prescription Dermatology and Eye Care Product Lines in - PharmiWeb.com

Nov 21, 2024

Nov 21, 2024

Amarin (AMRN) Stock Surges Amid Mixed Industry Performance - GuruFocus.com

Nov 21, 2024

Nov 21, 2024

Sonoma Pharmaceuticals Announces Relaunch of - One News Page

Nov 21, 2024

Nov 20, 2024

Sonoma Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 - Marketscreener.com

Nov 20, 2024

Nov 20, 2024

U.S. shares lower at close of trade; Dow Jones Industrial Average down 0.86% - MSN

Nov 20, 2024

Nov 14, 2024

Animal Wound Care Market to Exhibit a Remarkable CAGR of 7.9% - openPR

Nov 14, 2024

Nov 12, 2024

AMGN Stock Drops 5% Amid Industry Decline and Earnings Report - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Siga Technologies (SIGA) Sees Significant Stock Decline Amidst P - GuruFocus.com

Nov 12, 2024

Nov 12, 2024

Sonoma Pharmaceuticals gains FDA clearance for hydrogel By Investing.com - Investing.com Australia

Nov 12, 2024

Nov 12, 2024

Sonoma Pharmaceuticals (NASDAQ:SNOA) Share Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World

Nov 12, 2024

Nov 11, 2024

Sonoma Pharmaceuticals gains FDA clearance for hydrogel - Investing.com India

Nov 11, 2024

Nov 11, 2024

Sonoma Pharmaceuticals Receives New FDA 510(k) Clearance for Microcyn(R)-based Wound Care Hydrogel - AccessWire

Nov 11, 2024

Nov 11, 2024

Pre-market Movers: REVB, CDIO, SMLR, DWTX... - RTTNews

Nov 11, 2024

Nov 09, 2024

Sonoma Pharmaceuticals Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance

Nov 09, 2024

Nov 07, 2024

Sonoma Pharmaceuticals Inc. (SNOA) Quarterly 10-Q Report - Quartz

Nov 07, 2024

Nov 07, 2024

Sonoma Pharmaceuticals Inc (SNOA) Quarterly 10-Q Report - Quartzy

Nov 07, 2024

Nov 07, 2024

Sonoma Pharmaceuticals Reports Second Fiscal Quarter 2025 Financial Results - AccessWire

Nov 07, 2024